Segment, Customer and Geographical Reporting (Details) - USD ($)	3 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Sep. 30, 2015
Segment Reporting Information [Line Items]
Revenue	$ 11,204,000	$ 9,611,000
Gross Profit	$ 3,965,000	$ 3,593,000
GM %	35.40%	37.40%
SG&A	$ 3,805,000	$ 4,207,000
Gain on sale of assets	4,000	185,000
Operating Income (Loss)	164,000	(429,000)
Depreciation and Amortization	325,000	293,000
Capital expenditures	603,000	244,000
Intangibles, Net	1,197,000	1,271,000	$ 1,225,000
Goodwill	6,094,000	6,171,000	6,131,000
Total Assets	25,636,000	25,377,000	$ 24,462,000
Contract Research [Member]
Segment Reporting Information [Line Items]
Revenue	4,990,000	4,663,000
Gross Profit	$ 1,855,000	$ 2,098,000
GM %	37.20%	45.00%
SG&A	$ 1,706,000	$ 1,881,000
Gain on sale of assets	0	0
Operating Income (Loss)	149,000	216,000
Depreciation and Amortization	80,000	74,000
Capital expenditures	7,000	0
Intangibles, Net	256,000	290,000
Goodwill	4,939,000	4,939,000
Total Assets	8,273,000	9,036,000
Optics [Member]
Segment Reporting Information [Line Items]
Revenue	6,214,000	4,948,000
Gross Profit	$ 2,110,000	$ 1,495,000
GM %	34.00%	30.20%
SG&A	$ 1,751,000	$ 2,091,000
Gain on sale of assets	4,000	185,000
Operating Income (Loss)	363,000	(410,000)
Depreciation and Amortization	228,000	204,000
Capital expenditures	565,000	244,000
Intangibles, Net	644,000	752,000
Goodwill	1,155,000	1,232,000
Total Assets	16,506,000	15,419,000
Biomedical [Member]
Segment Reporting Information [Line Items]
Revenue	0	0
Gross Profit	$ 0	$ 0
GM %	0.00%	0.00%
SG&A	$ 348,000	$ 235,000
Gain on sale of assets	0	0
Operating Income (Loss)	(348,000)	(235,000)
Depreciation and Amortization	17,000	15,000
Capital expenditures	31,000	0
Intangibles, Net	297,000	229,000
Goodwill	0	0
Total Assets	$ 857,000	$ 922,000